
Navin Pinto MD
Pediatric Solid Tumor Oncology
Physician
Join to View Full Profile
13123 E 16th AveAurora, CO 80045
Dr. Pinto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Saint Louis University School of MedicineClass of 2005
Certifications & Licensure
- CO State Medical License 2023 - 2025
- WA State Medical License 2015 - 2024
- ID State Medical License 2021 - 2023
- IL State Medical License 2005 - 2017
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Locoregional Infusion of EGFR806-CAR T Cells for Recurrent or Refractory Pediatric CNS Tumors: Results of the Completed BrainChild02 Phase 1 Clinical Trial.Juliane Gust, Bonnie L Cole, Rebecca Ronsley, Ashley L Wilson, Kristy Seidel
Neuro-Oncology. 2025-03-12 - 1 citationsIntracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial.Nicholas A Vitanza, Rebecca Ronsley, Michelle Choe, Kristy Seidel, Wenjun Huang
Nature Medicine. 2025-03-01 - 2 citationsSTRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.Navin Pinto, Catherine M Albert, Mallory R Taylor, Heidi B Ullom, Ashley L Wilson
Journal of Clinical Oncology. 2024-12-10
Press Mentions
- Q&A: CAR T Cell Therapy Offers a Novel Approach to Pediatric Cancer TreatmentAugust 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: